Cell-mediated immunity in HBeAg-positive homosexuals with chronic liver disease.
AUTOR(ES)
Viola, L
RESUMO
Chronic liver disease developing after infection with the hepatitis B virus may be due to impairment of cell-mediated immunity (CMI). In a study of CMI by the lymphocyte transformation test to two mitogens and hepatitis B surface antigen (HBsAg) the response to the mitogens, phytohemagglutinin (PHA) and purified protein derivative (PPD), was normal in all of 15 male homosexuals with HBsAg-positive chronic liver disease, indicating a normal non-specific cellular immune response. By contrast, only one of the 15 patients showed a response to HBsAg, which may explain the high prevalence of chronic HBsAg carriage in these patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1046004Documentos Relacionados
- Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion
- Editorial: Diagnosis of cell-mediated immunity in ocular disease.
- Cell-mediated Immunity in Legionnaires' Disease
- Cell-mediated immunity in acute and chronic hepatitis.
- Cell-mediated immunity in Sjögren's syndrome.